Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul 23;11(7):2072.
doi: 10.3390/biomedicines11072072.

Airway Epithelium Senescence as a Driving Mechanism in COPD Pathogenesis

Affiliations
Review

Airway Epithelium Senescence as a Driving Mechanism in COPD Pathogenesis

Georgia Bateman et al. Biomedicines. .

Abstract

Cellular senescence is a state of permanent cell cycle arrest triggered by various intrinsic and extrinsic stressors. Cellular senescence results in impaired tissue repair and remodeling, loss of physiological integrity, organ dysfunction, and changes in the secretome. The systemic accumulation of senescence cells has been observed in many age-related diseases. Likewise, cellular senescence has been implicated as a risk factor and driving mechanism in chronic obstructive pulmonary disease (COPD) pathogenesis. Airway epithelium exhibits hallmark features of senescence in COPD including activation of the p53/p21WAF1/CIP1 and p16INK4A/RB pathways, leading to cell cycle arrest. Airway epithelial senescent cells secrete an array of inflammatory mediators, the so-called senescence-associated secretory phenotype (SASP), leading to a persistent low-grade chronic inflammation in COPD. SASP further promotes senescence in an autocrine and paracrine manner, potentially contributing to the onset and progression of COPD. In addition, cellular senescence in COPD airway epithelium is associated with telomere dysfunction, DNA damage, and oxidative stress. This review discusses the potential mechanisms of airway epithelial cell senescence in COPD, the impact of cellular senescence on the development and severity of the disease, and highlights potential targets for modulating cellular senescence in airway epithelium as a potential therapeutic approach in COPD.

Keywords: COPD; SASP; airway epithelial cells; cellular senescence; pathogenesis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest.

Figures

Figure 1
Figure 1
Mechanisms of airway epithelium senescence in COPD and potential therapeutic targets. Created using BioRender.com. Red boxes and solid lines represent senescence inducers and senescence signaling pathways. Light and darker green boxes and dotted lines represent potential therapeutic approches and drugs targeting senescence.
Figure 2
Figure 2
Possible mechanisms of SASP regulation on COPD airway epithelium. Created using BioRender.com. Red and dark red boxes represent key inducers that mediate the secretions of SASP through differenct signal pathways in an autocrine manner. Green writings and box represent mediators that are involed in spreading senesence to neighbouring cells in a paracrine manner.

References

    1. Agustí A., Celli B.R., Criner G.J., Halpin D., Anzueto A., Barnes P., Bourbeau J., Han M.K., Martinez F.J., Montes de Oca M., et al. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. Arch. Bronconeumol. 2023;59:232–248. doi: 10.1016/j.arbres.2023.02.009. - DOI - PubMed
    1. Jarhyan P., Hutchinson A., Khaw D., Prabhakaran D., Mohan S. Prevalence of chronic obstructive pulmonary disease and chronic bronchitis in eight countries: A systematic review and meta-analysis. Bull. World Health Organ. 2022;100:216–230. doi: 10.2471/BLT.21.286870. - DOI - PMC - PubMed
    1. Barnes P.J., Baker J., Donnelly L.E. Cellular Senescence as a Mechanism and Target in Chronic Lung Diseases. Am. J. Respir. Crit. Care Med. 2019;200:556–564. doi: 10.1164/rccm.201810-1975TR. - DOI - PubMed
    1. Pando-Sandoval A., Ruano-Ravina A., Candal-Pedreira C., Rodríguez-García C., Represas-Represas C., Golpe R., Fernández-Villar A., Pérez-Ríos M. Risk factors for chronic obstructive pulmonary disease in never-smokers: A systematic review. Clin. Respir. J. 2022;16:261–275. doi: 10.1111/crj.13479. - DOI - PMC - PubMed
    1. Postma D.S., Rabe K.F. The Asthma-COPD Overlap Syndrome. N. Engl. J. Med. 2015;373:1241–1249. doi: 10.1056/NEJMra1411863. - DOI - PubMed